ストックスクリーナーアプリを入手
9.9721
1.69%
0.1662
アフターアワーズ：
9.97
-0.0021
-0.02%
Global X Genomics Biotechnology Etf (GNOM) 最新ニュース
Stifel Financial Corp Reduces Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Jane Street Group LLC Sells 16,550 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Learn to Evaluate (GNOM) using the Charts - Stock Traders Daily
Rockefeller Capital Management L.P. Acquires Shares of 18,186 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Best-Performing ETF Areas of Last Week - Yahoo Finance
Atria Investments Inc Invests $122,000 in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
When (GNOM) Moves Investors should Listen - Stock Traders Daily
Top Tech ETFs Right Now - Benzinga
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Top Canadian Genetics Stocks of 2024 - The Motley Fool Canada
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
(GNOM) Proactive Strategies - Stock Traders Daily
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Time for Healthcare ETFs? - Yahoo Finance
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now - U.S News & World Report Money
The Next Big Theme: June 2024 - Global X
9 Best Biotech ETFs for 2024 - MSN
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Biotech Funds Underperform the Broader Market - Trackinsight
Gene Therapy: A Cure for Cancer? - Opto RoW
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
3 Biotech ETFs to Bet on Now - Nasdaq
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 - InvestorPlace
The Next Big Theme: December 2023 - Global X
VettaFi Voices On: The Outlook for 2024 - ETF Trends
The Next Big Theme: November 2023 - Global X
The Genomic Medicine Revolution - Global X
This Rally Seemed To Come Out Of Nowhere. It Didn’t. - Finimize
AI Applications in Healthcare: From Drug Discovery to Patient Care - Global X
How to Invest in Genetics - Investing News Network
Top Biotech Stocks to Invest InDiscover the Best Biotech Stocks to Watch - Opto RoW
3 Gene Editing Stocks to Generate Super-Charged Gains - Markets Insider
0.77%
大文字化:
|
ボリューム (24 時間):